347 related articles for article (PubMed ID: 16735375)
1. CCL27 is a critical factor for the development of atopic dermatitis in the keratin-14 IL-4 transgenic mouse model.
Chen L; Lin SX; Agha-Majzoub R; Overbergh L; Mathieu C; Chan LS
Int Immunol; 2006 Aug; 18(8):1233-42. PubMed ID: 16735375
[TBL] [Abstract][Full Text] [Related]
2. The development of atopic dermatitis is independent of Immunoglobulin E up-regulation in the K14-IL-4 SKH1 transgenic mouse model.
Chen L; Overbergh L; Mathieu C; Chan LS
Clin Exp Allergy; 2008 Aug; 38(8):1367-80. PubMed ID: 18489026
[TBL] [Abstract][Full Text] [Related]
3. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation.
Homey B; Alenius H; Müller A; Soto H; Bowman EP; Yuan W; McEvoy L; Lauerma AI; Assmann T; Bünemann E; Lehto M; Wolff H; Yen D; Marxhausen H; To W; Sedgwick J; Ruzicka T; Lehmann P; Zlotnik A
Nat Med; 2002 Feb; 8(2):157-65. PubMed ID: 11821900
[TBL] [Abstract][Full Text] [Related]
4. Increased CCL27-CCR10 expression in allergic contact dermatitis: implications for local skin memory.
Moed H; Boorsma DM; Tensen CP; Flier J; Jonker MJ; Stoof TJ; von Blomberg BM; Bruynzeel DP; Scheper RJ; Rustemeyer T; Gibbs S
J Pathol; 2004 Sep; 204(1):39-46. PubMed ID: 15307136
[TBL] [Abstract][Full Text] [Related]
5. A possible role for CCL27/CTACK-CCR10 interaction in recruiting CD4 T cells to skin in human graft-versus-host disease.
Faaij CM; Lankester AC; Spierings E; Hoogeboom M; Bowman EP; Bierings M; Révész T; Egeler RM; van Tol MJ; Annels NE
Br J Haematol; 2006 Jun; 133(5):538-49. PubMed ID: 16681643
[TBL] [Abstract][Full Text] [Related]
6. CCL27-transgenic mice show enhanced contact hypersensitivity to Th2, but not Th1 stimuli.
Kagami S; Saeki H; Tsunemi Y; Nakamura K; Kuwano Y; Komine M; Nakayama T; Yoshie O; Tamaki K
Eur J Immunol; 2008 Mar; 38(3):647-57. PubMed ID: 18266301
[TBL] [Abstract][Full Text] [Related]
7. Presence of circulating CCR10+ T cells and elevated serum CTACK/CCL27 in the early stage of mycosis fungoides.
Fujita Y; Abe R; Sasaki M; Honda A; Furuichi M; Asano Y; Norisugi O; Shimizu T; Shimizu H
Clin Cancer Res; 2006 May; 12(9):2670-5. PubMed ID: 16675558
[TBL] [Abstract][Full Text] [Related]
8. Topical suplatast tosilate (IPD) ameliorates Th2 cytokine-mediated dermatitis in caspase-1 transgenic mice by downregulating interleukin-4 and interleukin-5.
Murakami T; Yamanaka K; Tokime K; Kurokawa I; Tsutsui H; Nakanishi K; Mizutani H
Br J Dermatol; 2006 Jul; 155(1):27-32. PubMed ID: 16792748
[TBL] [Abstract][Full Text] [Related]
9. CTACK/CCL27 accelerates skin regeneration via accumulation of bone marrow-derived keratinocytes.
Inokuma D; Abe R; Fujita Y; Sasaki M; Shibaki A; Nakamura H; McMillan JR; Shimizu T; Shimizu H
Stem Cells; 2006 Dec; 24(12):2810-6. PubMed ID: 16931770
[TBL] [Abstract][Full Text] [Related]
10. The progression of inflammation parallels the dermal angiogenesis in a keratin 14 IL-4-transgenic model of atopic dermatitis.
Chen L; Marble DJ; Agha R; Peterson JD; Becker RP; Jin T; Li J; Chan LS
Microcirculation; 2008 Jan; 15(1):49-64. PubMed ID: 17952801
[TBL] [Abstract][Full Text] [Related]
11. Potential role of CCL27 and CCR10 expression in melanoma progression and immune escape.
Simonetti O; Goteri G; Lucarini G; Filosa A; Pieramici T; Rubini C; Biagini G; Offidani A
Eur J Cancer; 2006 May; 42(8):1181-7. PubMed ID: 16644201
[TBL] [Abstract][Full Text] [Related]
12. IL-17 suppresses TNF-alpha-induced CCL27 production through induction of COX-2 in human keratinocytes.
Kanda N; Koike S; Watanabe S
J Allergy Clin Immunol; 2005 Nov; 116(5):1144-50. PubMed ID: 16275389
[TBL] [Abstract][Full Text] [Related]
13. CCR4 and CCR10 are expressed on epidermal keratinocytes and are involved in cutaneous immune reaction.
Fujimoto S; Uratsuji H; Saeki H; Kagami S; Tsunemi Y; Komine M; Tamaki K
Cytokine; 2008 Oct; 44(1):172-8. PubMed ID: 18782672
[TBL] [Abstract][Full Text] [Related]
14. TARC augments TNF-alpha-induced CTACK production in keratinocytes.
Vestergaard C; Johansen C; Christensen U; Just H; Hohwy T; Deleuran M
Exp Dermatol; 2004 Sep; 13(9):551-7. PubMed ID: 15335355
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha-induced CTACK/CCL27 (cutaneous T-cell-attracting chemokine) production in keratinocytes is controlled by nuclear factor kappaB.
Vestergaard C; Johansen C; Otkjaer K; Deleuran M; Iversen L
Cytokine; 2005 Jan; 29(2):49-55. PubMed ID: 15598438
[TBL] [Abstract][Full Text] [Related]
16. The disease progression in the keratin 14 IL-4-transgenic mouse model of atopic dermatitis parallels the up-regulation of B cell activation molecules, proliferation and surface and serum IgE.
Chen L; Lin SX; Overbergh L; Mathieu C; Chan LS
Clin Exp Immunol; 2005 Oct; 142(1):21-30. PubMed ID: 16178852
[TBL] [Abstract][Full Text] [Related]
17. Cytokine production, activation marker, and skin homing receptor in children with atopic dermatitis and bronchial asthma.
Antúnez C; Torres MJ; Mayorga C; Corzo JL; Jurado A; Santamaría-Babi LF; Vera A; Blanca M
Pediatr Allergy Immunol; 2006 May; 17(3):166-74. PubMed ID: 16672002
[TBL] [Abstract][Full Text] [Related]
18. Thymus- and activation-regulated chemokine (TARC/CCL17) induces a Th2-dominated inflammatory reaction on intradermal injection in mice.
Vestergaard C; Deleuran M; Gesser B; Larsen CG
Exp Dermatol; 2004 Apr; 13(4):265-71. PubMed ID: 15086343
[TBL] [Abstract][Full Text] [Related]
19. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis.
Hijnen D; De Bruin-Weller M; Oosting B; Lebre C; De Jong E; Bruijnzeel-Koomen C; Knol E
J Allergy Clin Immunol; 2004 Feb; 113(2):334-40. PubMed ID: 14767451
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis: the major abnormality of the keratin-14 IL-4 transgenic mouse model of atopic dermatitis.
Agha-Majzoub R; Becker RP; Schraufnagel DE; Chan LS
Microcirculation; 2005 Sep; 12(6):455-76. PubMed ID: 16147464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
